27 octubre 2014
A live attenuated enterotoxigenic Escherichia coli vaccine candidate, given in combination with a novel adjuvant, provided significant protection against disease, new results from a safety and immunogenicity study, which included a challenge phase to test efficacy, indicate.
http://feeds.sciencedaily.com/~r/sciencedaily/~3/8CBDkCGlnes/141027100453.htm
